Research Topics
| Rosita SaracenoSummaryCountry: Italy Publications
| Collaborators
|
Detail Information
Publications
An Italian study on psoriasis and depressionMaria Esposito
Department of Dermatology, Tor Vergata University of Rome, Policlinico Tor Vergata, Viale Oxford 81, IT-00133 Rome, Italy
Dermatology 212:123-7. 2006..It is important to consider this association in the overall management of psoriasis...
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasisRosita Saraceno
Department of Dermatology, University of Rome Tor Vergata PTV, Viale Oxford 81, 00133 Rome, Italy
Pharmacol Res 57:290-5. 2008..BMI and body weight did not interfere with the drugs' efficacy. We report a significant weight-gain associated with three different anti-TNF-alpha therapies in a large number of patients affected with psoriasis...
An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularisRosita Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
J Dermatolog Treat 21:363-6. 2010..Prurigo nodularis is a distressing condition characterized by the presence of multiple nodules associated with intense pruritus...
TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasisRosita Saraceno
University of Rome Tor Vergata, Department of Dermatology, Policlinico Tor Vergata, Viale Oxford 81, 00133, Rome, Italy
Expert Opin Biol Ther 13:469-73. 2013..Treatment of nail psoriasis can be challenging and unsatisfactory. The aim of this study was to compare the efficacy of three different anti-TNF-α agents on nail psoriasis in patients affected by psoriasis...
Prevalence and management of panic attacks during infliximab infusion in psoriatic patientsR Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Dermatology 225:236-41. 2012..Psoriasis is a chronic, inflammatory skin disease associated with anxiety and depression. Infliximab (IFX) is a human/mouse chimeric anti-TNF-α antibody effective in the treatment of psoriasis...
Does metabolic syndrome influence psoriasis?R Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Eur Rev Med Pharmacol Sci 12:339-41. 2008..Moreover we suggest that diet counselling and regular nutritional visits should be recommended in some patients to obtain dual benefits...
Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subjectRosita Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Clin Ther 30:1324-9. 2008..Hydroxyurea is a cytostatic agent used to treat myeloproliferative disorders and long-term treatment is associated with mucocutaneous adverse events and nail hyperpigmentation...
Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled studyRosita Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Dermatol Ther 22:391-4. 2009..MEL 308 nm, alone and/or combined with khellin 4% offered encouraging results and it may be considered a valid therapeutic option worthy of consideration in the treatment of vitiligo...
Calcipotriene/betamethasone in the treatment of psoriasis: a review articleRosita Saraceno
Policlinico Tor Vergata University of Rome Tor Vergata, Department of Dermatology, Viale Oxford 81, 00133 Rome, Italy
Expert Opin Pharmacother 10:2357-65. 2009..In this article, we highlight the advantages of the association of calcipotriene and betamethasone in the treatment of localized plaque-type, scalp and nail psoriasis...
Regional distribution of psoriasis in ItalyR Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
J Eur Acad Dermatol Venereol 22:324-9. 2008..Psoriasis is a chronic disease affecting skin and joints; the prevalence varies considerably within ethnic groups and countries...
Methyl aminolaevulinate photodynamic therapy for the treatment of hidradenitis suppurativa and pilonidal cystsRosita Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Photodermatol Photoimmunol Photomed 25:164-5. 2009..MAL-PDT was effective and well tolerated in our patient. The costs of this therapy represent an important limitation, taking into account the high number of sessions that were performed compared with non-melanoma skin cancers...
Monochromatic excimer light (308 nm) in the treatment of prurigo nodularisRosita Saraceno
Department of Dermatology, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy
Photodermatol Photoimmunol Photomed 24:43-5. 2008..Patients were treated weekly and an average of eight sessions of MEL was given. Follow-up was 4 months. Partial or complete clinical and histological remission was observed in all patients who completed the study (81%)...
A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapyR Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Clin Exp Dermatol 33:154-5. 2008..Coexistence of psoriasis vulgaris with bullous diseases represents also a difficult therapeutic challenge. This rare case of psoriasis and generalized BP triggered by a sartan drug was treated with rituximab and etanercept...
Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trialRosita Saraceno
Department of Dermatology, University of Rome Tor Vergata, Viale Oxford 81, Rome, Italy
J Dermatolog Treat 18:361-5. 2007....
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatmentLaura D I Renzo
Division of Human Nutrition, Department of Neuroscience, University of Rome Tor Vergata, Italy
Dermatol Ther 24:446-51. 2011..The anti-TNF-α therapies could play a key role in the cross talk between adipose tissue and skeletal muscle, mediated by the reduction of TNF-α and interleukin-6 production...
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockersLaura Di Renzo
Department of Neuroscience, Division of Human Nutrition, University of Rome Tor Vergata, Italy
Pharmacogenet Genomics 22:134-42. 2012..Although TNF-α blockade is a very effective therapy for psoriasis, not all patients achieve a favorable outcome. The association between IL-6 and psoriasis has been investigated but no papers have focused on the pharmacogenetics of IL-6...
Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled studySteven Nistico
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Photomed Laser Surg 30:26-30. 2012..However, a complete and long-lasting repigmention of vitiligo patches is difficult to achieve. Combined treatments with novel sources of phototherapy and topical agents represent possible new strategies...
Different applications of monochromatic excimer light in skin diseasesSteven Paul Nisticò
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Photomed Laser Surg 27:647-54. 2009..Ultraviolet radiation has been used for curative purposes in dermatologic conditions, especially in the last 30 years...
Complete resolution of erythrodermic psoriasis in an HIV and HCV patient unresponsive to antipsoriatic treatments after highly active antiretroviral therapy (Ritonavir, Atazanavir, Emtricitabine, Tenofovir)Andrea Chiricozzi
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Dermatology 225:333-7. 2012..The management of this condition is challenging because immunomodulating and immunosuppressant agents may have variable and partial efficacy, and therefore, antiretroviral treatment represents a potential adjunctive therapeutic option...
Erysipeloid cutaneous metastasis from bladder carcinomaArianna Zangrilli
Department of Dermatology, University of Rome Tor Vergata, Viale Oxford 81, 00133, Rome, Italy
Eur J Dermatol 17:534-6. 2007..We report this case for the unusual clinical features and because an early recognition of cutaneous metastases from genitourinary malignancies is important in clinical practice...
Treatment of folliculitis with monochromatic excimer light (308 nm)Steven P Nisticò
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Dermatology 218:33-6. 2009..The aim of the study was to prove the efficacy of 308-nm monochromatic excimer light in the treatment of recalcitrant and antibiotic-resistant folliculitis...
How to manage infections in the era of biologics?Rosita Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Dermatol Ther 21:180-6. 2008..A prompt and appropriate management of infections with the emergence of biologics is essential in clinical practice...
Recent patents and new strategies in the treatment of psoriasisRosita Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Recent Patents Anti-Infect Drug Disc 1:353-64. 2006....
Profile of certolizumab and its potential in the treatment of psoriatic arthritisMaria Sole Chimenti
Unit of Rheumatology, Allergology, and Clinical Immunology, University of Rome Tor Vergata, Rome, Italy
Drug Des Devel Ther 7:339-48. 2013..This drug can be considered as a valid treatment in patients affected by PsA. The efficacy and tolerability profiles suggest CZP as a suitable antipsoriatic drug in the treatment of PsA...
Efficacy of monochromatic excimer light (308 nm) in the treatment of atopic dermatitis in adults and childrenSteven Paul Nisticò
Department of Dermatology, Policlinico Tor Vergata, Rome, Italy
Photomed Laser Surg 26:14-8. 2008..To demonstrate the efficacy of light produced by a 308 nm xenon-chloride monochromatic excimer light (MEL) in the treatment of localized lesions of atopic dermatitis (AD) in adults and in children...
"Bathing trunk" eruption of papules and nodules in a young woman. Eruptive disseminated Spitz naeviAndrea Saggini
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Acta Derm Venereol 91:738-9. 2011
Infliximab in the treatment of plaque type psoriasisRosita Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Viale Oxford 81, Rome, Italy
Clin Cosmet Investig Dermatol 2:27-37. 2009..The efficacy, tolerability and safety profiles suggest infliximab as a suitable anti-psoriatic drug in the long-term treatment of a chronic disease such as plaque-type psoriasis...
Emerging applications of nanomedicine in dermatologyRosita Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Skin Res Technol 19:e13-9. 2013..AIMS: To review therapeutic applications and benefits of nanomedicine in esthetic dermatology, treatment of malignancies, and inflammatory skin diseases...
Recent patents on melanoma with focus on genetic strategiesTalia Gramiccia
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Recent Pat Antiinfect Drug Discov 3:136-44. 2008..The focus of this review is to summarize the emerging patents in the treatment and diagnosis of melanoma related to the latest genetic models and bio-molecular discoveries...
A 308-nm monochromatic excimer light in the treatment of palmoplantar psoriasisS P Nisticò
Department of Dermatology, University of Rome, Tor Vergata, Italy
J Eur Acad Dermatol Venereol 20:523-6. 2006..Various reports have shown the efficacy of narrow-band UVB (311-313 nm) and excimer laser (308 nm) in the treatment of psoriasis...
Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasisM Esposito
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Int J Immunopathol Pharmacol 22:219-25. 2009..Patient BMI does not influence psoriasis efficacy parameters. Although the role of anti TNF-alpha molecules on weight regulation need to be confirmed, our study shows that etanercept treatment may induce weight gain and a BMI increase...
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasisMaria Esposito
J Infect 57:90-2. 2008
A European perspective on the challenges of managing psoriasisRosita Saraceno
Dermatology Centre, The University of Manchester, Hope Hospital, Manchester, United Kingdom
J Am Acad Dermatol 54:S81-4. 2006
